Compare Hinge Health Inc. Class A Common Stock (HNGE) vs TORM plc (TRMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs TORM plc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while TORM plc trades at $38.8 (market cap $4.12B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 2.1× TORM plc's market cap, and TORM plc pays a 11.07% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and TORM plc for 23 Days on average.
| HNGE | TRMD | |
|---|---|---|
Market Cap | $8.47B | $4.12B |
Volume | 1,624,526 | 2,428,655 |
Sector | Health | Industrials |
52-Week High | $105.14 | $41.11 |
52-Week Low | $31.17 | $19.39 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $8.09B | $4.83B |
Dividend Yield | — | 11.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
TRMD trades at $41.11, up 0.46% today, with a bullish technical signal from moving averages and strong fundamentals including a P/E of 6.56 and net income margin of 35.52%. Recent earnings showed a Q2 2026 miss but a Q4 2025 beat, while revenue is projected to grow from $1.34B in 2025 to $1.8B in 2026. A $2.40 dividend is scheduled for September 2026, and analyst consensus is unanimously bullish with 3 buy ratings.
The outlook for TRMD is positive due to robust profitability and low valuation, but risks include declining spot rates and insider selling. Upside potential hinges on sustained freight demand, while near-term pressure may arise from earnings volatility and competitive tanker markets. Investors should weigh the high dividend yield against cyclical industry exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →
